219 related articles for article (PubMed ID: 19306417)
61. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study.
Huang CY; Tang YH; Chiang YC; Wang KL; Fu HC; Ke YM; Lau HY; Hsu KF; Wu CH; Cheng WF
Gynecol Oncol; 2014 May; 133(2):221-8. PubMed ID: 24556064
[TBL] [Abstract][Full Text] [Related]
62. Uterine papillary serous carcinoma: a new paradigm for treatment?
Annunziata CM; Kotz HL
Cancer; 2009 Aug; 115(16):3594-6. PubMed ID: 19452535
[No Abstract] [Full Text] [Related]
63. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
[TBL] [Abstract][Full Text] [Related]
64. Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcoma.
Matsuo K; Ross MS; Yunokawa M; Johnson MS; Machida H; Omatsu K; Klobocista MM; Im DD; Satoh S; Baba T; Ikeda Y; Bush SH; Hasegawa K; Blake EA; Takekuma M; Shida M; Nishimura M; Adachi S; Pejovic T; Takeuchi S; Yokoyama T; Ueda Y; Iwasaki K; Miyake TM; Yanai S; Nagano T; Takano T; Shahzad MMK; Ueland FR; Kelley JL; Roman LD
Gynecol Oncol; 2017 Dec; 147(3):565-571. PubMed ID: 29056442
[TBL] [Abstract][Full Text] [Related]
65. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.
Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA
J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917
[TBL] [Abstract][Full Text] [Related]
66. Uterine serous carcinoma: Reassessing effectiveness of platinum-based adjuvant therapy.
Tortorella L; Langstraat CL; Weaver AL; McGree ME; Bakkum-Gamez JN; Dowdy SC; Cliby WA; Keeney GL; Sherman ME; Weroha SJ; Mariani A; Podratz KC
Gynecol Oncol; 2018 May; 149(2):291-296. PubMed ID: 29550183
[TBL] [Abstract][Full Text] [Related]
67. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma.
Rauh-Hain JA; Growdon WB; Schorge JO; Goodman AK; Boruta DM; McCann C; Horowitz NS; del Carmen MG
Gynecol Oncol; 2010 Nov; 119(2):299-304. PubMed ID: 20691465
[TBL] [Abstract][Full Text] [Related]
68. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
69. Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.
Lindahl B; Persson J; Ranstam J; Willén R
Anticancer Res; 2010 Sep; 30(9):3727-30. PubMed ID: 20944161
[TBL] [Abstract][Full Text] [Related]
70. FIGO stage III and IV uterine papillary serous carcinoma: impact of residual disease on survival.
Memarzadeh S; Holschneider CH; Bristow RE; Jones NL; Fu YS; Karlan BY; Berek JS; Farias-Eisner R
Int J Gynecol Cancer; 2002; 12(5):454-8. PubMed ID: 12366662
[TBL] [Abstract][Full Text] [Related]
71. Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy.
Steed H; Manchul L; Rosen B; Fyles A; Lockwood G; Laframboise S; Murphy J; Milosevic M; Chapman W; Oza AM
Int J Gynecol Cancer; 2006; 16 Suppl 1():278-85. PubMed ID: 16515604
[TBL] [Abstract][Full Text] [Related]
72. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma.
Thomas MB; Mariani A; Cliby WA; Keeney GL; Podratz KC; Dowdy SC
Gynecol Oncol; 2007 Nov; 107(2):190-3. PubMed ID: 17825394
[TBL] [Abstract][Full Text] [Related]
73. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.
Slomovitz BM; Burke TW; Eifel PJ; Ramondetta LM; Silva EG; Jhingran A; Oh JC; Atkinson EN; Broaddus RR; Gershenson DM; Lu KH
Gynecol Oncol; 2003 Dec; 91(3):463-9. PubMed ID: 14675663
[TBL] [Abstract][Full Text] [Related]
74. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
[TBL] [Abstract][Full Text] [Related]
75. Low drug resistance to both platinum and taxane chemotherapy on an in vitro drug resistance assay predicts improved survival in patients with advanced epithelial ovarian, fallopian and peritoneal cancer.
Matsuo K; Bond VK; Eno ML; Im DD; Rosenshein NB
Int J Cancer; 2009 Dec; 125(11):2721-7. PubMed ID: 19530239
[TBL] [Abstract][Full Text] [Related]
76. Uterine Clear Cell Carcinoma: Does Adjuvant Chemotherapy Improve Outcomes?
Nguyen JM; Bouchard-Fortier G; Bernardini MQ; Atenafu EG; Han G; Vicus D; Ferguson SE; Gien LT
Int J Gynecol Cancer; 2017 Jan; 27(1):69-76. PubMed ID: 27668398
[TBL] [Abstract][Full Text] [Related]
77. [Comparison of primary extraovarian peritoneal serous papillary carcinoma with stage III-IV ovarian papillary serous carcinoma].
Gao YN; Liu JX; Wang W; Li WF; Tang WS
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):171-3. PubMed ID: 15946570
[TBL] [Abstract][Full Text] [Related]
78. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review.
Growdon WB; Rauh-Hain JJ; Cordon A; Garrett L; Schorge JO; Goodman A; Boruta DM; Horowitz NS; del Carmen MG
Int J Gynecol Cancer; 2012 Mar; 22(3):417-24. PubMed ID: 22237383
[TBL] [Abstract][Full Text] [Related]
79. Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.
Craighead PS; Sait K; Stuart GC; Arthur K; Nation J; Duggan M; Guo D
Gynecol Oncol; 2000 May; 77(2):248-53. PubMed ID: 10785473
[TBL] [Abstract][Full Text] [Related]
80. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
